Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/121819
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ukena, C. | - |
dc.contributor.author | Mahfoud, F. | - |
dc.contributor.author | Ewen, S. | - |
dc.contributor.author | Bollmann, A. | - |
dc.contributor.author | Hindricks, G. | - |
dc.contributor.author | Hoffmann, B.A. | - |
dc.contributor.author | Linz, D. | - |
dc.contributor.author | Musat, D. | - |
dc.contributor.author | Pavlicek, V. | - |
dc.contributor.author | Scholz, E. | - |
dc.contributor.author | Thomas, D. | - |
dc.contributor.author | Willems, S. | - |
dc.contributor.author | Böhm, M. | - |
dc.contributor.author | Steinberg, J.S. | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Clinical Research in Cardiology, 2016; 105(10):873-879 | - |
dc.identifier.issn | 1861-0684 | - |
dc.identifier.issn | 1861-0692 | - |
dc.identifier.uri | http://hdl.handle.net/2440/121819 | - |
dc.description.abstract | Introduction: Ventricular arrhythmias (VAs) in patients with chronic heart failure (CHF) are sometimes refractory to antiarrhythmic drugs and cardiac ablation. This study aimed to investigate catheter-based renal sympathetic denervation (RDN) as antiarrhythmic strategy in refractory VA. Methods: These are the first data from a pooled analysis of 13 cases from five large international centers (age 59.2 ± 14.4 years, all male) with CHF (ejection fraction 25.8 ± 10.1 %, NYHA class 2.6 ± 1) presented with refractory VA who underwent RDN. Ventricular arrhythmias, ICD therapies, clinical status, and blood pressure (BP) were evaluated before and 1–12 months after RDN. Results: Within 4 weeks prior RDN, a median of 21 (interquartile range 10–30) ventricular tachycardia (VT) or fibrillation (VF) episodes occurred despite antiarrhythmic drugs and prior cardiac ablation. RDN was performed bilaterally with a total number of 12.5 ± 3.5 ablations and without peri-procedural complications. One and 3 months after RDN, VT/VF episodes were reduced to 2 (0–7) (p = 0.004) and 0 (p = 0.006), respectively. Four (31 %) and 11 (85 %) patients of these 13 patients were free from VA at 1 and 3 months. Although BP was low at baseline (116 ± 18/73 ± 13 mmHg), no significant changes of BP or NYHA class were observed after RDN. During follow-up, three patients died from non-rhythm-related causes. Conclusions: In patients with CHF and refractory VA, RDN appears to be safe concerning peri-procedural complications and blood pressure changes, and is associated with a reduced arrhythmic burden. | - |
dc.description.statementofresponsibility | Christian Ukena, Felix Mahfoud, Sebastian Ewen, Andreas Bollmann, Gerhard Hindricks, Boris A. Hoffmann, Dominik Linz, Dan Musat, Valerie Pavlicek, Eberhard Scholz, Dierk Thomas, Stephan Willems, Michael Böhm, Jonathan S. Steinberg | - |
dc.language.iso | en | - |
dc.publisher | Springer | - |
dc.rights | © Springer-Verlag Berlin Heidelberg 2016 | - |
dc.source.uri | http://dx.doi.org/10.1007/s00392-016-1012-y | - |
dc.subject | Heart failure; ventricular fibrillation; electrical storm; renal denervation | - |
dc.title | Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1007/s00392-016-1012-y | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Linz, D. [0000-0003-4893-0824] | - |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.